![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Regeneron Pharmaceuticals Inc | BOV:REGN34 | Bovespa | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 64.71 | 60.10 | 70.00 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
0 | 20:54:54 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
17 Feb 2025 | 64.71 | -0.33 | -0.51% | 64.71 | 64.71 | 1 |
14 Feb 2025 | 65.04 | 0.32 | 0.49% | 60.11 | 65.45 | 36 |
13 Feb 2025 | 64.72 | -3.28 | -4.82% | 64.28 | 64.72 | 86 |
12 Feb 2025 | 68.00 | -0.04 | -0.06% | 68.00 | 68.00 | 1 |
11 Feb 2025 | 68.04 | 0.00 | 0.00% | 68.04 | 68.04 | 0 |
10 Feb 2025 | 68.04 | -1.06 | -1.53% | 68.04 | 68.04 | 2 |
07 Feb 2025 | 69.10 | 0.16 | 0.23% | 68.90 | 69.21 | 638 |
06 Feb 2025 | 68.94 | 1.68 | 2.50% | 68.94 | 70.30 | 131 |
05 Feb 2025 | 67.26 | 0.00 | 0.00% | 66.99 | 67.26 | 3 |
04 Feb 2025 | 67.26 | 2.59 | 4.00% | 63.00 | 67.30 | 51 |
03 Feb 2025 | 64.67 | -1.07 | -1.63% | 64.56 | 65.70 | 8,005 |
31 Jan 2025 | 65.74 | -1.21 | -1.81% | 65.52 | 66.96 | 103 |
30 Jan 2025 | 66.95 | -1.09 | -1.60% | 66.95 | 67.34 | 588 |
29 Jan 2025 | 68.04 | 0.24 | 0.35% | 68.04 | 68.32 | 19 |
28 Jan 2025 | 67.80 | 0.00 | 0.00% | 67.80 | 67.80 | 0 |
27 Jan 2025 | 67.80 | 1.07 | 1.60% | 66.46 | 68.60 | 74 |
24 Jan 2025 | 66.73 | -0.05 | -0.07% | 66.73 | 73.00 | 8 |
23 Jan 2025 | 66.78 | -2.17 | -3.15% | 66.78 | 67.76 | 11 |
22 Jan 2025 | 68.95 | 0.00 | 0.00% | 68.95 | 68.95 | 0 |
21 Jan 2025 | 68.95 | 1.04 | 1.53% | 68.95 | 69.16 | 243 |
20 Jan 2025 | 67.91 | -3.77 | -5.26% | 67.91 | 69.38 | 124 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions